- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04337671
Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery Hypertension
April 3, 2020 updated by: Heba Ahmed Ali Abdeen, Cairo University
Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery Hypertension: a Randomized Control Study
This study investigated the effect of 12 weeks of aerobic training on sleep quality and aerobic fitness in patients with Pulmonary arterial hypertension(PAH).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Thirty male PAH patients were included in the study.
They were randomized into two equal groups; Training group (A) and Control group(B).
Right ventricular systolic pressure (RVSP) measured using Doppler Echocardiography , Pittsburg sleep quality index (PSQI) questionnaire with the wrist worn actigraph used for the assessment of sleep disturbance, and Cardiopulmonary exercise testing (CPET) measurements included maximal heart rate and VO2max .All were measured before and after the study period for both groups.The training was a moderate intensity aerobic training on a bicycle ergometer (corresponding to 60% to 70% of the maximal heart rate they reach during peak oxygen uptake in the initial exercise test) for 30 to 45 min/day, 3 sessions/week for 12 weeks (36 sessions).
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 12316
- Faculty of physical therapy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Patients who were clinically stable and compensated under optimized medical therapy
- World health organization (WHO) Classification of functional class II to III PAH
- Patients with ejection fraction ≥ 40%
- Non-smokers
- body mass index ≤ 35 kg/m2
Exclusion Criteria:
- Any patient with respiratory failure
- unstable angina
- renal, hepatic or neuromuscular disorders
- history of syncopal attacks
- uncontrolled systemic hypertension
- peripheral vascular disease
- serious cardiac dysrhythmias on resting ECG
- evidence of severe COPD at pulmonary function testing,
- any known musculoskeletal or neurological conditions that might interfere with the execution or the assessment of the exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Training group (A)
The training was a moderate intensity aerobic training on a bicycle ergo-meter(corresponding to 60% to 70% of the maximal heart rate they reach during peak oxygen uptake in the initial exercise test) for 30 to 45 min/day, 3 sessions/week for 12 weeks (36 sessions).
In addition to their prescribed medications.
|
The exercise program consisted of 5 minutes warm-up, 15-30 minutes of moderate aerobic exercises and 10 minutes cool-down, respectively. Frequency: 3 sessions/week , and Duration:12 weeks. |
No Intervention: control group (B)
Control group not receiving any training .
They are taking their prescribed medications only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pulmonary artery systolic pressure (PASP)
Time Frame: change from baseline at 12 weeks
|
Pulsed Doppler Echocardiogram for assessing PASP as calculated from the gradient across the tricuspid valve using the modified Bernoulli equation.
|
change from baseline at 12 weeks
|
Subjective self-report questionnaire that assesses sleep quality
Time Frame: change from baseline at 12 weeks
|
The Pittsburgh Sleep Quality Index is a subjective self-report questionnaire that assesses sleep quality over a 1-month time interval in different populations It is 5 points score (0 means normal, 5 means severe sleep disturbance)
|
change from baseline at 12 weeks
|
Determining sleep patterns
Time Frame: change from baseline at 12 weeks
|
Determining sleep patterns by using actigraph to assess suspected certain sleep disorders,
|
change from baseline at 12 weeks
|
Measuring aerobic fitness
Time Frame: change from baseline at 12 weeks
|
Level of aerobic fitness assessed by using Cardiopulmonary exercise testing (CPET) through incremental exercise intensity until voluntary exhaustion.
|
change from baseline at 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 2, 2018
Primary Completion (Actual)
November 29, 2019
Study Completion (Actual)
December 28, 2019
Study Registration Dates
First Submitted
March 31, 2020
First Submitted That Met QC Criteria
April 3, 2020
First Posted (Actual)
April 8, 2020
Study Record Updates
Last Update Posted (Actual)
April 8, 2020
Last Update Submitted That Met QC Criteria
April 3, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019HAHA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Artery Hypertension
-
Assistance Publique - Hôpitaux de ParisCompletedHypoxia-Induced Pulmonary Artery HypertensionFrance
-
University of ZurichCompletedPulmonary Hypertension | Pulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary HypertensionSwitzerland
-
Bastiaan DriehuysRegeneron PharmaceuticalsWithdrawnPulmonary Artery Hypertension
-
Gazi UniversityActive, not recruitingPulmonary HypertensionTurkey
-
Sheffield Teaching Hospitals NHS Foundation TrustActelionCompletedPulmonary Artery HypertensionUnited Kingdom
-
University of ZurichActive, not recruitingPulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary Hypertension | Pulmonary Vascular DiseaseSwitzerland
-
University of ZurichActive, not recruitingPulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary Hypertension | Pulmonary Vascular DiseaseSwitzerland
-
University of ZurichActive, not recruitingPulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary Hypertension | Pulmonary Vascular DisorderSwitzerland
-
University of ZurichActive, not recruitingPulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary Hypertension | Pulmonary Vascular DiseaseSwitzerland
-
Imperial College LondonNot yet recruitingPulmonary Artery Hypertension
Clinical Trials on Moderate intensity aerobic training
-
Riphah International UniversityRecruitingPsychological Well-BeingPakistan
-
Norwegian University of Science and TechnologyCompleted
-
Fundación para la Investigación del Hospital Clínico...RecruitingHeart Failure With Preserved Ejection Fraction | Chronotropic IncompetenceSpain
-
Cairo UniversityCompleted
-
National Taiwan University HospitalUnknownPhysical Activity | Exercise | Metabolic Syndrome XTaiwan
-
Federal University of UberlandiaTerminatedHypertension | MenopauseBrazil
-
University of South CarolinaCompletedObstructive Sleep ApneaUnited States
-
Federal University of ParaíbaCompletedChronic Disease | Overweight and Obesity
-
Badr UniversityUnknown
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted